In Memorium  by Hirsch, Fred R. & Bunn, Paul A.
IN MEMORIUM
IASLC Newsletter
It is with deep sadness the IASLC received the message that one of its Founders, Prof. 
Heine Hoi Hansen passed away in Copenhagen, September 16. 2011.
Dr. Hansen was at the National Cancer Institute (NCI) in 
1972 when a group of lung cancer investigators decided 
to arrange the First International Workshop for Therapy 
of Lung Cancer at Airlie House Conference Center in 
Virginia sponsored by the US NCI.  At that meeting it 
was decided to make a lung cancer society to promote 
research and education in lung cancer and Dr. Hansen 
was instrumental in the development.  IASLC society 
was formally established in 1974 and the 1st World 
Conference was held in Hilton Head, SC, US in 1977. 
The 2nd World Conference on Lung Cancer was held in 
Copenhagen in 1980 and Heine H. Hansen was the Congress President.   
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Heine H. Hansen served on the IASLC Board of Directors from 1985 -1994 and served as 
the IASLC President 1988-1991. In 1994 he was selected as the IASLC Executive 
Director and established an IASLC Headquarters in Copenhagen. He served in this role 
as Executive Director until 2003 and during this period there was remarkable growth in 
IASLC membership and WCLC attendees.
Legend above.  From left to right: Paul A. Bunn, Jr, 
Ronald Vincent, Y. Hayata, George Higgins, Clifton 
Mountain, Oleg Selawry, Heine H. Hansen.
Legend above. Former IASLC Presidents, Clifton 
Mountain, Heine H. Hansen, and David T. Carr,  - a
joyous reunion at the 10th World Conference, 
Vancouver 2003.
Heine H. Hansen founded the official IASLC Journal “Lung Cancer”, which was 
published for the first time in 1985, and Dr. Hansen was the Editor-in-Chief until 2005.
Heine H. Hansen has also played a significant role in the 
development of medical oncology in Europe and served as 
President of ESMO (1995-1997) and later instrumental in the 
development of a global curriculum in medical oncology, a 
work he led in conjunction with ESMO and ASCO.
Heine H. Hansen made a significant scientific contribution to 
development of chemotherapy for solid tumors and 
particularly lung cancer. He made the Finsen Institute in Copenhagen to an international 
research center for lung cancer in general and small cell carcinoma in particular and 
moved that to the National University Hospital (Rigshospitalet) for further development. 
He was instrumental in the development of cancer clinical trials in Europe and mentored 
many clinical oncologists.
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Heine H. Hansen was a dynamic leader both for the IASLC and other organizations as 
well as for national and international research in lung cancer, and he has received 
numerous international awards.
Legend: IASLC Distinguished Service 
Award, Vancouver 2003. Former 
President, Dr. H. Kato presents the 
Award to Dr. Heine H. Hansen.
Our thoughts these days go to his wife, Lise, who stood with his side throughout the 
whole career and the two children, Thomas and Marie with their families.
The IASLC has lost an instrumental leader. His footsteps are heavily printed, and may his 
legacy be to a blessing for the new generation of lung cancer investigators and all the 
patients waiting for new developments! 
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